17 results on '"Gasparro D"'
Search Results
2. Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study
3. Physiological effects of sleeping with the head of the bed elevated 18 in. in young healthy volunteers
4. Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training
5. Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes
6. A case of resistance to thyroid hormone without mutation in the thyroid hormone receptor beta
7. Papel sinérgico con doble trazador PET/TC con18F-FDG y68GA-PSMA en la detección de recurrencia del carcinoma papilar de células renales.
8. Fixed investment decisions in UK manufacturing: the importance of Tobin's Q, output and debt
9. The effects of acute and chronic exercise on insulin sensitivity in obesity and type 2 diabetes
10. Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma.
11. Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes.
12. The effects of acute and chronic exercise on insulin sensitivity in obesity and type 2 diabetes.
13. The clinical and metabolic features of Irish patients with acanthosis nigricans.
14. LBA71 Open-label, multicentre randomised trial of Radium223-docetaxel versus docetaxel-Radium223 sequence in metastatic castration resistant prostate cancer (mCRPC) with prospective biomarker evaluation (RAPSON study).
15. 1815P Emergent circulating tumor DNA (ctDNA) variants and ctDNA burden dynamics with potential associations with talazoparib antitumor activity in TALAPRO-1.
16. P181 - 68Ga-PSMA-HBED-CC pet as new imaging biomarker of clear cell renal cancer (CCRCC).
17. 1368P TALAPRO-1: Talazoparib monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage response alterations (DDRm) – Exploration of tumor genetics associated with prolonged benefit.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.